Antipsychotics are the best defense against relapse in schizophrenia, even though that protection often comes at the expense ...

By Puyaan Singh and Bhanvi Satija (Reuters) -AbbVie shares fell over 12% on Monday after an experimental schizophrenia drug ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Earlier antipsychotics all work by directly regulating dopamine, a vital brain-cell-signaling chemical that can cause ...

The following is a summary of “Analysis of the Incidence and Outcomes of Breast Cancer in Women with Schizophrenia,” published in the November 2024 issue of Surgery by Den et al. Worldwide, breast ...

Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...

Shares in AbbVie slumped by double digits Monday after the company disclosed its psychiatric medicine emraclidine didn’t best ...

Typically, they are treated with antipsychotics. But those have side effects including severe constipation, confusion and ...

While antipsychotic medication reduces the risk of relapse for patients with schizophrenia, high prevalence of adverse effects results in low adherence. Lower doses of antipsychotics have been ...

Luckily, multiple treatments exist that can help you manage the condition. Medications such as mood stabilizers, antipsychotics, and benzodiazepines can be used alone or in combination with other ...